General Information of the Compound
Compound ID
CP0944313
Compound Name
4-(5-(3-Chlorophenyl)-1-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)phenol
    Show/Hide
Structure
Formula
C21H16Cl2N2O
Molecular Weight
383.278
Canonical SMILES
Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3cccc(Cl)c3)C2)cc1
    Show/Hide
InChI
InChI=1S/C21H16Cl2N2O/c22-16-6-8-18(9-7-16)25-21(15-2-1-3-17(23)12-15)13-20(24-25)14-4-10-19(26)11-5-14/h1-12,21,26H,13H2
    Show/Hide
InChIKey
VTPGYBNMLSMRMN-UHFFFAOYSA-N
Physicochemical Property
logP
6.0547
Rotatable Bonds
3
Heavy Atom Count
26
Polar Areas
35.83
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145981790
ChEMBL ID
CHEMBL4282313
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00924, Protein kinase C zeta type
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 < 100 nM
   TI
   LI
   LO
   TS